ArticleScientific reports2022

Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.